{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:53:47Z","timestamp":1787871227872,"version":"build-2784847793"},"reference-count":41,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2002,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The efficiency of postexposure prophylaxis against<jats:italic>Bacillus anthracis<\/jats:italic>infection was tested in guinea pigs infected intranasally with either Vollum or strain ATCC 6605 spores (75 times the 50% lethal dose [LD<jats:sub>50<\/jats:sub>] and 87 times LD<jats:sub>50,<\/jats:sub>respectively). Starting 24 h postinfection, animals were treated three times per day for 14 days with ciprofloxacin, tetracycline, erythromycin, cefazolin, and trimethoprim-sulfamethoxazole (TMP-SMX). Administration of cefazolin and TMP-SMX failed to protect the animals, while ciprofloxacin, tetracycline, and erythromycin prevented death. Upon cessation of treatment all erythromycin-treated animals died; of the tetracycline-treated animals, two of eight infected with Vollum and one of nine infected with ATCC 6605 survived; and of the ciprofloxacin group injected with either 10 or 20 mg\/kg of body weight, five of nine and five of five animals, respectively, survived. To test the added value of extending the treatment period, Vollum-infected (46 times the LD<jats:sub>50<\/jats:sub>) animals were treated for 30 days with ciprofloxacin or tetracycline, resulting in protection of eight of nine and nine of nine animals, respectively. Once treatment was discontinued, only four of eight and five of nine animals, respectively, survived. Following rechallenge (intramuscularly) of the survivors with 30 times the LD<jats:sub>50<\/jats:sub>of Vollum spores, all ciprofloxacin-treated animals were protected while none of the tetracycline-treated animals survived. In an attempt to confer protective immunity lasting beyond the termination of antibiotic administration, Vollum-infected animals were immunized with a protective antigen (PA)-based vaccine concurrently with treatment with either ciprofloxacin or tetracycline. The combined treatment protected eight of eight and nine of nine animals. Following cessation of antibiotic administration seven of eight and eight of eight animals survived, of which six of seven and eight of eight resisted rechallenge. These results indicate that a combined treatment of antibiotics together with a PA-based vaccine could provide long-term protection to prevent reoccurrence of anthrax disease.<\/jats:p>","DOI":"10.1128\/iai.70.11.6231-6241.2002","type":"journal-article","created":{"date-parts":[[2002,10,15]],"date-time":"2002-10-15T02:36:49Z","timestamp":1034649409000},"page":"6231-6241","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":60,"title":["Postexposure Prophylaxis against Anthrax: Evaluation of Various Treatment Regimens in Intranasally Infected Guinea Pigs"],"prefix":"10.1128","volume":"70","author":[{"given":"Zeev","family":"Altboum","sequence":"first","affiliation":[{"name":"Departments of Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehoshua","family":"Gozes","sequence":"additional","affiliation":[{"name":"Departments of Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Barnea","sequence":"additional","affiliation":[{"name":"Biotechnology, Israel Institute for Biological Research, Ness-Ziona 74100, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Pass","sequence":"additional","affiliation":[{"name":"Biotechnology, Israel Institute for Biological Research, Ness-Ziona 74100, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"White","sequence":"additional","affiliation":[{"name":"Biotechnology, Israel Institute for Biological Research, Ness-Ziona 74100, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kobiler","sequence":"additional","affiliation":[{"name":"Departments of Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"113","volume":"194","year":"1947","unstructured":"Barnes, J. M. 1947. Penicillin and B. anthracis. J. Pathol. Bacteriol.194:113-125.","journal-title":"J. Pathol. Bacteriol."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/br.30.3.646-659.1966"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1980.tb18910.x"},{"key":"e_1_3_2_5_2","first-page":"306","volume":"340","year":"1992","unstructured":"Bradic, N., and V. Punda-Polic. 1992. Cutaneous anthrax due to penicillin resistant Bacillus anthracis transmitted by insect bite. Lancet340:306-307.","journal-title":"Lancet"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012948"},{"key":"e_1_3_2_7_2","unstructured":"Centers for Disease Control and Prevention. 22 October 2001 posting date. CDC update: Antimicrobial susceptibility of Bacillus anthracis isolates associated with intentional distribution in Florida New Jersey New York Pennsylvania Virginia and Washington D.C. September-October 2001. http:\/\/www.bt.cdc.gov\/DocumentsApp\/Anthrax\/10222001Advisory\/10222001advisory.asp ."},{"key":"e_1_3_2_8_2","first-page":"941","volume":"50","year":"2001","unstructured":"Centers for Disease Control and Prevention. 2001. CDC update: investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. Morb. Mortal. Wkly. Rep.50:941-948.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_9_2","first-page":"973","volume":"50","year":"2001","unstructured":"Centers for Disease Control and Prevention. 2001. CDC update: investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis. Morb. Mortal. Wkly. Rep.50:973-976.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_10_2","first-page":"1014","volume":"50","year":"2001","unstructured":"Centers for Disease Control and Prevention. 2001. Interim recommendations for antimicrobial prophylaxis for children and breastfeeding mothers and treatment of children with anthrax. Morb. Mortal. Wkly. Rep.50:1014-1016.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_11_2","first-page":"1051","volume":"50","year":"2001","unstructured":"Centers for Disease Control and Prevention. 2001. Adverse events associated with anthrax prophylaxis among postal employees\u2014New Jersey, New York City, and the District of Columbia Metropolitan Area. Morb. Mortal. Wkly. Rep.50:1051-1054.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_12_2","first-page":"1077","volume":"50","year":"2001","unstructured":"Centers for Disease Control and Prevention. 2001. Investigation of bioterrorism-related anthrax - Connecticut. Morb. Mortal. Wkly. Rep.50:1077-1079.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.8.4549-4558.2000"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909093411107"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365549109024319"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.5.1239"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0022172400039279"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880337"},{"key":"e_1_3_2_19_2","first-page":"13","volume":"225","year":"1998","unstructured":"Hanna, P. 1998. Anthrax pathogenesis and host response. Curr. Top. Microbiol. Immunol.225:13-35.","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.85.2.451-460.1963"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0022172400044272"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.18.1735"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)90027-2"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(95)00139-R"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3201\/eid0706.010604","volume":"7","year":"2001","unstructured":"Jerigen, J. A., D. S. Stephens, D. A. Ashford, C. Omenca, M. S. Topiel, M. Galbraith, M. Tapper, T. L. Fisk, S. Zaki, T. Popocic, R. F. Meyer, C. P. Quin, S. A. Harper, S. F. Fridkin, J. J. Sejvar, C. W. Shepard, M. McConnell, J. Guarner, W. J. Shieh, J. M. Malecki, J. L. Gerberding, J. M. Hughes, and B. A. Perkins. 2001. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States: Emerg. Infect. Dis.7:933-944.","journal-title":"Infect. Dis."},{"key":"e_1_3_2_26_2","unstructured":"Salisbury Med. Bull. 1996 87"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.94.3.609-614.1967"},{"key":"e_1_3_2_28_2","first-page":"544","volume":"70","year":"2001","unstructured":"Kobiler, D., Y. Gozes, H. Rosenberg, D. Marcos, S. Reuveny, and Z. Altboum. 2001. Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization. Infect. Immun.70:544-560.","journal-title":"Infect. Immun."},{"key":"e_1_3_2_29_2","first-page":"95","volume":"68","year":"1990","unstructured":"Lightfoot, N. F., R. J. D. Scott, and P. C. B. Turnbull. 1990. Antimicrobial susceptibility of Bacillus anthracis. Salisbury Med. Bull.68(Sp. Suppl.):95-98.","journal-title":"Salisbury Med. Bull."},{"key":"e_1_3_2_30_2","first-page":"759","volume":"4","year":"1964","unstructured":"Lincoln, R. E., F. Klein, J. S. Walker, B. W. Haines, W. I. Jones, B. G. Mahlandt, and R. H. Friedman. 1964. Successful treatment of monkeys for septicemia anthrax. Antimicrob. Agent Chemother.4:759-763.","journal-title":"Antimicrob. Agent Chemother."},{"key":"e_1_3_2_31_2","first-page":"327","volume":"9","year":"1965","unstructured":"Lincoln, R. E., J. S. Walker, F. Klein, and B. W. Haines. 1965. Anthrax. Adv. Vet. Sci.9:327-368.","journal-title":"Anthrax. Adv. Vet. Sci."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.12.5171-5175.1997"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7973702"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1944.02850500020005"},{"key":"e_1_3_2_35_2","unstructured":"National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press Washington D.C."},{"key":"e_1_3_2_36_2","first-page":"261","volume":"66","year":"2002","unstructured":"Quintiliani, R., Jr., and R. Quintiliani. 2002. Fatal case of inhalational anthrax mimicking intra-abdominal sepsis. Conn. Med.66:261-267.","journal-title":"Conn. Med."},{"key":"e_1_3_2_37_2","first-page":"493","volume":"27","year":"1938","unstructured":"Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty percent end points. Am. J. Hyg.27:493-497.","journal-title":"Am. J. Hyg."},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.5.2888-2893.2001"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1700730219"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1438-4221(00)80030-2"},{"key":"e_1_3_2_41_2","unstructured":"Turnbull P. C. B. 1998. Guidelines for the surveillance and control of anthrax in humans and animals 3rd ed. World Health Organization Geneva Switzerland."},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02875859"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.70.11.6231-6241.2002","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.70.11.6231-6241.2002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T11:34:08Z","timestamp":1733830448000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.70.11.6231-6241.2002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["10.1128\/IAI.70.11.6231-6241.2002"],"URL":"https:\/\/doi.org\/10.1128\/iai.70.11.6231-6241.2002","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11]]},"assertion":[{"value":"2002-04-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-08-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-11-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}